Formulary design and management -designing cost effective preferred drug lists or exclusions, to meet the needs of both the patient population and the payer

   Disease state management - providing drug and disease information designed to empower and better educate patients about their medications and disease, in an effort to ultimately lower overall benefit costs

   Clinical decision support - the ability to combine prescription and medical data and offer a powerful reporting package

   Drug utilization review - monitoring drug usage and evaluating other anomalies

   Patient education - assisting with utilization compliance and better patient outcomes by targeting members that could benefit from clinical education

   Medication compliance programs - providing rules which flag noncompliance, and follow-up procedures to ensure utilization is consistent, enhancing patient outcomes and lowering overall benefit costs

   P&T committee support - ensuring clinical programs meet rigorous P&T committee standards

   Clinical Theranomics^SM - HealthTrans' process for evaluating the clinical economic value of drugs. The program is designed to optimize the overall value of the Rx benefit

   Physician education/target drug programs - Useful drug cost information to enhance the physician prescribing process

   Patient/provider profiling - review of prescribing trends identifying possible fraud and or abuse

   Therapeutic class review and monograph development - Reviews are performed on a regular basis to incorporate significant changes, such as a new drug, and how they effect the market. When a new drug comes to market a detailed drug monograph is developed

   Therapeutic protocol development - clinically sound protocols designed to enhance outcomes with the most cost effective therapy

   Pipeline analysis - Prior to FDA approval, HealthTrans reviews the drug's potential impact on cost and therapy choices